期刊文献+

Fhit、P14^(ARF)及Caspase-3在子宫内膜腺癌中的表达及意义 被引量:3

Expression of Fhit, P14^(ARF), Caspase-3 in the Endometrial Adenocarcinoma and Its Clinical Significance
下载PDF
导出
摘要 探讨Fhit、P14ARF、Caspase-3蛋白在子宫内膜腺癌(EA)、子宫内膜不典型增生(EIN)、正常子宫内膜中的表达及意义。采用免疫组化SP法检测60例EA、30例EIN、30例正常子宫内膜中Fhit、P14ARF、Caspase-3蛋白的表达及相关性。结果显示,EA中三种蛋白的阳性表达率显著低于正常子宫内膜组织(P<0.01)。Fhit的阳性表达与EA的手术-病理分期、组织分级、肌层浸润和淋巴转移相关(P<0.05),P14ARF、Caspase-3的阳性表达仅与EA的组织分级相关(P<0.01)。在EA中三种蛋白间存在明显正相关性(均P<0.01)。结果表明,三种蛋白的表达下降,可能对子宫内膜腺癌的早期诊断、发生发展和判断预后具有一定的参考价值。 The paper detected the expression of the Fhit, P14^ARF and Caspase-3 protein in endometrial adenocarcinoma (EA), endometrial atypical hyperplasia (EIN) and the normal endometrium and its clinical significance. The expression and relevance of Fhit, P14^ARF and Caspase-3 protein in 60 cases of EA, 30 cases of EIN and 30 cases of normal endometrial tissue were detected by streptavidin-perosidase (SP) immunohistochemical staining. The positive rates of the three protein in EA were significantly lower than those in normal endometrium (P〈0.01). The positive expression of Fhit was related to the surgical-pathologic staging of EA, organizational grade, myometrial invasion and lymph node metastasis (P〈0.05). The positive expressions of P14^ARF and Caspase-3 were only related to the organizational grade of EA (P〈0.01). The every two protein of the three protein were all of significant positive correlation in EA (P〈0.01). Decrease in the three protein expression has certain reference value in early diagnosis, progression and prognosis of the EA.
出处 《莆田学院学报》 2015年第2期21-26,共6页 Journal of putian University
关键词 子宫内膜腺癌 FHIT P14^ARF CASPASE-3 免疫组织化学 endometrial adenocarcinoma Fhit P14^ARF Caspase-3 immunohistochemistry
  • 相关文献

参考文献16

  • 1连丽娟,刘彤华,刘炽明,等.林巧稚妇科肿瘤学[M].3版.北京:人民卫生出版社,2001,329-372.
  • 2Ohta M, Inoue H, Cotticelli M G, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3; 8) breakpoint, is abnormal in digestive tract cancers[J]. Cell, 1996, 84(4):587-597.
  • 3Saldivar J C, Bene J, Hosseini S A, et al. Characterization of the role of Fhit in suppression of DNA damage[J]. Adv Biol Regul, 2013, 53(1):77-85.
  • 4Jeong Y J, Jeong H Y, Lee S M, et al. Promoter methylation status of the FHIT gene and FHIT expression association with HER2/neu status in breast cancer patients [J]. Oncol Rep, 2013, 30(5):2270-2278.
  • 5李铭,袁宏银.FHIT基因与肿瘤[J].数理医药学杂志,2006,19(2):187-190. 被引量:3
  • 6Diaz R J, Guduk M, Romagnuolo R, et al. High- resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis[J]. Neoblasia, 2012, 14(9):788-798.
  • 7蒋小英,臧春逸.FHIT和Cyclin D1与子宫内膜癌的相关性[J].广东医学,2011,32(9):1137-1139. 被引量:2
  • 8赵文科,牛兆山.子宫内膜腺癌组织中FHIT蛋白的表达及其意义[J].青岛大学医学院学报,2007,43(3):250-252. 被引量:6
  • 9Yura Y, Mandai protein expression M, Konishi I, et al. Loss of Fhit in high-grade and endometrial carcinomas [J]. Anticancer (3c): 2837-2843. advanced stage Res, 2003, 23.
  • 10Michalides R J. Cell cycle regulators: mechanisms and their role in aetiology, prognosis and treatment of caner [J]. J Clin Pathol, 1999, 52(8):555-568.

二级参考文献56

  • 1马爱荣,崔竹梅,戴淑真,王福玲.S100在子宫内膜癌中的表达及其意义[J].齐鲁医学杂志,2004,19(6):477-480. 被引量:9
  • 2葛伟平,齐卫红,兰晓明.p16、Rb和rasp21蛋白在子宫内膜癌组织中的表达[J].齐鲁医学杂志,2005,20(2):139-141. 被引量:7
  • 3周正斌,杨大明,沈琴,徐静,孟宪镛.熊去氧胆酸诱导肝癌细胞株HepG2凋亡及对Survivin、Caspase-3表达的影响[J].胃肠病学和肝病学杂志,2006,15(5):492-496. 被引量:5
  • 4牛兆山,张昭成,邹伟.增生结节、肝硬变及肝癌组织中原癌基因 C-erbB-2 蛋白产物的表达[J].青岛医学院学报,1997,33(1):30-32. 被引量:6
  • 5MAEDA K,CHUNG Y S,KANG S M,et al.Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma[J].Int J Cancer,1997,74(3):310-315.
  • 6HAO X P,WILLIS J E,PRETLOW T G,et al.Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions[J].Cancer Res,2000,60(1):18-21.
  • 7ROZ L,GRAMEGNA M,ISHII H,et al.Restiration of fragile histidine triad(FHIT)expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines[J].Proc Natl Acad Sci U S A,2002,99(6):3615-3620.
  • 8YUGE T,NIBU K,KONDO K,et al.Loss of FHIT expression in squamous cell carcinoma and premalignant lesions of the larynx[J].Ann Otol Rhinol Laryngol,2005,114(2):127-131.
  • 9GALMARINI C M,KAMATH K,VANIER VIORNERY A,et al.Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics[J].Br J Cancer,2003,88(11):1793-1799.
  • 10PEREZ ORDONEZ B,BEAUCHEMIN M,JORDAN R C.Molecular biology of squamous cell carcinoma of the head and neck[J].J Clin Pathol,2006,59(5):445-453.

共引文献15

同被引文献24

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部